Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,774
Total Claims
$1.4M
Drug Cost
487
Beneficiaries
$2,967
Cost/Patient
Risk Score Breakdown 13/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-41%
Opioid rate vs peers
1.5% vs 2.6% avg
+178%
Cost per patient vs peers
$2,967 vs $1,068 avg
+70%
Brand preference vs peers
15.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
1.5%
Opioid Rate
164
Opioid Claims
$1,830
Opioid Cost
7.3%
Long-Acting Rate
Brand vs Generic
Brand: 1,631 claims · $1.2M
Generic: 9,046 claims · $198K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Empagliflozin | 173 | $155K |
| Semaglutide | 117 | $149K |
| Tirzepatide | 97 | $124K |
| Apixaban | 122 | $115K |
| Dulaglutide | 77 | $115K |
| Fluticasone/Umeclidin/Vilanter | 65 | $78K |
| Mirabegron | 84 | $52K |
| Insulin Glargine,hum.Rec.Anlog | 63 | $40K |
| Sitagliptin Phosphate | 38 | $37K |
| Linagliptin | 44 | $34K |
| Umeclidinium Brm/Vilanterol Tr | 47 | $32K |
| Rivaroxaban | 27 | $27K |
| Insulin Aspart | 19 | $24K |
| Fluticasone/Vilanterol | 32 | $16K |
| Insulin Glargine,hum.Rec.Anlog | 23 | $15K |
Prescribing Profile
Patient Profile
74
Avg Age
71%
Female
1.25
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About